These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

785 related articles for article (PubMed ID: 31307986)

  • 21. In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Candida spp. as determined by CLSI broth microdilution method.
    Pfaller MA; Hata K; Jones RN; Messer SA; Moet GJ; Castanheira M
    Diagn Microbiol Infect Dis; 2011 Oct; 71(2):167-70. PubMed ID: 21696907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.
    Pfaller MA; Messer SA; Rhomberg PR; Castanheira M
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fungicidal efficacy of various honeys against fluconazole-resistant Candida species isolated from HIV
    Shokri H; Sharifzadeh A
    J Mycol Med; 2017 Jun; 27(2):159-165. PubMed ID: 28159362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic antifungal effect of lactoferrin with azole antifungals against Candida albicans and a proposal for a new treatment method for invasive candidiasis.
    Kobayashi T; Kakeya H; Miyazaki T; Izumikawa K; Yanagihara K; Ohno H; Yamamoto Y; Tashiro T; Kohno S
    Jpn J Infect Dis; 2011; 64(4):292-6. PubMed ID: 21788703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spectrum of activity and mechanisms of azole-bisphosphonate synergy in pathogenic
    Kane A; Dinh H; Campbell L; Cain AK; Hibbs D; Carter D
    Microbiol Spectr; 2024 Jun; 12(6):e0012124. PubMed ID: 38695556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole.
    Quan H; Cao YY; Xu Z; Zhao JX; Gao PH; Qin XF; Jiang YY
    Antimicrob Agents Chemother; 2006 Mar; 50(3):1096-9. PubMed ID: 16495278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic in vitro activity of sodium houttuyfonate with fluconazole against clinical Candida albicans strains under planktonic growing conditions.
    Shao J; Cui Y; Zhang M; Wang T; Wu D; Wang C
    Pharm Biol; 2017 Dec; 55(1):355-359. PubMed ID: 27931143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antifungal susceptibilities, in vitro production of virulence factors and activities of ceragenins against Candida spp. isolated from vulvovaginal candidiasis.
    Hacioglu M; Guzel CB; Savage PB; Tan ASB
    Med Mycol; 2019 Apr; 57(3):291-299. PubMed ID: 29846682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [In vitro activity of fluconazole, voriconazole and posaconazole against Candida spp].
    Rubio Calvo MC; Gil J; Ramírez de Ocáriz I; Benito R; Rezusta A
    Rev Esp Quimioter; 2003 Jun; 16(2):227-32. PubMed ID: 12973462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of Rezafungin Provisional CLSI Clinical Breakpoints and Epidemiological Cutoff Values Tested against a Worldwide Collection of Contemporaneous Invasive Fungal Isolates (2019 to 2020).
    Carvalhaes CG; Klauer AL; Rhomberg PR; Pfaller MA; Castanheira M
    J Clin Microbiol; 2022 Apr; 60(4):e0244921. PubMed ID: 35249367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro antifungal resistance profile of Candida strains isolated from Saudi women suffering from vulvovaginitis.
    Yassin MT; Mostafa AA; Al-Askar AA; Bdeer R
    Eur J Med Res; 2020 Jan; 25(1):1. PubMed ID: 31901238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential effect of 2-isopropyl-5-methylphenol (thymol) alone and in combination with fluconazole against clinical isolates of Candida albicans, C. glabrata and C. krusei.
    Sharifzadeh A; Khosravi AR; Shokri H; Shirzadi H
    J Mycol Med; 2018 Jun; 28(2):294-299. PubMed ID: 29661606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of micafungin against biofilms of Candida albicans, Candida glabrata, and Candida parapsilosis at different stages of maturation.
    Prażyńska M; Bogiel T; Gospodarek-Komkowska E
    Folia Microbiol (Praha); 2018 Mar; 63(2):209-216. PubMed ID: 28983822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. APX001A
    Arendrup MC; Chowdhary A; Astvad KMT; Jørgensen KM
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of posaconazole minimum fungicidal concentration and time kill test against nine Candida species.
    Sóczó G; Kardos G; McNicholas PM; Balogh E; Gergely L; Varga I; Kelentey B; Majoros L
    J Antimicrob Chemother; 2007 Nov; 60(5):1004-9. PubMed ID: 17875607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro susceptibility of oral Candida to seven antifungal agents.
    Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
    Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
    Panizo MM; Reviákina V; Dolande M; Selgrad S
    Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Posaconazole susceptibility testing against Candida species: comparison of broth microdilution and E-test methods.
    Sóczó G; Kardos G; McNicholas PM; Falusi E; Gergely L; Majoros L
    Mycoses; 2007 May; 50(3):178-82. PubMed ID: 17472612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activity of ibrexafungerp against Candida species isolated from blood cultures. Determination of wild-type populations using the EUCAST method.
    Mesquida A; Díaz-García J; Sánchez-Carrillo C; Muñoz P; Escribano P; Guinea J
    Clin Microbiol Infect; 2022 Jan; 28(1):140.e1-140.e4. PubMed ID: 34619396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey.
    Dagi HT; Findik D; Senkeles C; Arslan U
    Ann Clin Microbiol Antimicrob; 2016 May; 15(1):36. PubMed ID: 27245756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.